SUCCESSFUL USE OF A DARUNAVIR/RITONAVIR IN FIVE PREGNANT WOMEN: PHARMACOKINETICS, EFFICACY AND SAFETY

被引：0
|
作者：
Ivanovic, J. [1 ]
Bellagamba, R. [1 ]
Tempestilli, M. [1 ]
Signore, F. [2 ]
Vallone, C. [2 ]
Pisani, G. [2 ]
Nicastri, E. [1 ]
Tommasi, C. [1 ]
Gallo, A. L. [1 ]
Fezza, R. [1 ]
Pucillo, L. P. [1 ]
Narciso, P. [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy
[2] San Camillo Forlanini Hosp, Dept Obstet & Gynaecol, Rome, Italy
来源：
INFECTION | 2011年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women
    Cohan, Deborah
    Natureeba, Paul
    Koss, Catherine A.
    Plenty, Albert
    Luwedde, Flavia
    Mwesigwa, Julia
    Ades, Veronica
    Charlebois, Edwin D.
    Gandhi, Monica
    Clark, Tamara D.
    Nzarubara, Bridget
    Achan, Jane
    Ruel, Theodore
    Kamya, Moses R.
    Havlir, Diane V.
    AIDS, 2015, 29 (02) : 183 - 191
  • [32] Safety of antidepressant use in pregnant and nursing women
    Lamberg, L
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03): : 222 - 222
  • [33] The efficacy and safety of cervical polypectomy with vaginoscopy in pregnant women
    Zhang, Luping
    Wang, Ming
    Zhang, Shengpeng
    Han, Dan
    Guo, Lei
    Feng, Limin
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (04) : 1945 - 1950
  • [34] Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
    Schalkwijk, Stein
    ter Heine, Rob
    Colbers, Angela
    Capparelli, Edmund
    Best, Brookie M.
    Cressey, Tim R.
    Greupink, Rick
    Russel, Frans G. M.
    Molto, Jose
    Mirochnick, Mark
    Karlsson, Mats O.
    Burger, David M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1348 - 1356
  • [35] Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort
    Brunet, C.
    Reliquet, V.
    Jovelin, T.
    Venisse, N.
    Winer, N.
    Bui, E.
    Le Moal, G.
    Perfezou, P.
    De Saint Martin, L.
    Raffi, F.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (09): : 421 - 428
  • [36] Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naive and -experienced patients. (vol 9, pg 418, 2009)
    Bofitto, M.
    HIV CLINICAL TRIALS, 2009, 10 (02): : VI - VI
  • [37] Gender-specific differences in the pharmacokinetics of ritonavir (RTV)-boosted saquinavir (SQV) in men, women and pregnant women.
    von Hentig, NH
    Haberl, A
    Klauke, S
    Locher, L
    Staszewski, S
    Harder, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P31 - P31
  • [38] Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women
    Izurieta, P.
    Kakuda, T. N.
    Feys, C.
    Witek, J.
    HIV MEDICINE, 2011, 12 (04) : 257 - 258
  • [39] Pharmacokinetics and Safety of the Integrase Inhibitors Elvitegravir and Dolutegravir in Pregnant Women With HIV
    Binh Nguyen
    Foisy, Michelle M.
    Hughes, Christine A.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 833 - 844
  • [40] Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients
    Zucman, David
    De Truchis, P.
    Peytavin, Gilles
    Descamps, Diane
    Duvivier, C.
    Tegna, L.
    Weiss, Laurence
    Delassus, Jean L.
    Benalycherif, A.
    Landman, Roland
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (05) : 407 - 410
12345